gard –slovakexperience · microsoft powerpoint - 1_zakopane.ppt author: deslooverep created date:...
TRANSCRIPT
![Page 1: GARD –Slovakexperience · Microsoft PowerPoint - 1_Zakopane.ppt Author: deslooverep Created Date: 3/26/2007 5:42:39 PM](https://reader033.vdocuments.us/reader033/viewer/2022050101/5f407c5e8bb2152da37b6254/html5/thumbnails/1.jpg)
GARD – Slovak experience
Ladislav Chovan
Department of pneumology and phtisiology
Slovak Medical University
Univeristy Hospital Bratislava
![Page 2: GARD –Slovakexperience · Microsoft PowerPoint - 1_Zakopane.ppt Author: deslooverep Created Date: 3/26/2007 5:42:39 PM](https://reader033.vdocuments.us/reader033/viewer/2022050101/5f407c5e8bb2152da37b6254/html5/thumbnails/2.jpg)
![Page 3: GARD –Slovakexperience · Microsoft PowerPoint - 1_Zakopane.ppt Author: deslooverep Created Date: 3/26/2007 5:42:39 PM](https://reader033.vdocuments.us/reader033/viewer/2022050101/5f407c5e8bb2152da37b6254/html5/thumbnails/3.jpg)
Pneumology and phthisiology…?
![Page 4: GARD –Slovakexperience · Microsoft PowerPoint - 1_Zakopane.ppt Author: deslooverep Created Date: 3/26/2007 5:42:39 PM](https://reader033.vdocuments.us/reader033/viewer/2022050101/5f407c5e8bb2152da37b6254/html5/thumbnails/4.jpg)
Pneumology
and phthisiologyPneumology
and phthisiology
![Page 5: GARD –Slovakexperience · Microsoft PowerPoint - 1_Zakopane.ppt Author: deslooverep Created Date: 3/26/2007 5:42:39 PM](https://reader033.vdocuments.us/reader033/viewer/2022050101/5f407c5e8bb2152da37b6254/html5/thumbnails/5.jpg)
Myocardial infarction
� Acute event
� Risk of fatality
� Influencing following
course of disease
� Effective treatment
available – also for
secondary prevention
Exacerbation of COPD
� Acute event
� Risk of fatality
� Influencing following
course f the disease
� Effective treatment
available – also for
secondray prevention
Cardiology vs PaF
![Page 6: GARD –Slovakexperience · Microsoft PowerPoint - 1_Zakopane.ppt Author: deslooverep Created Date: 3/26/2007 5:42:39 PM](https://reader033.vdocuments.us/reader033/viewer/2022050101/5f407c5e8bb2152da37b6254/html5/thumbnails/6.jpg)
Development of selected
pulmonary diseases in the period
2001-2004
Number Change
2001 2006
COPD 54801 91433 + 78%
Asthma 47854 69971 + 46%
Fibriosis 2826 1884 + 50%
![Page 7: GARD –Slovakexperience · Microsoft PowerPoint - 1_Zakopane.ppt Author: deslooverep Created Date: 3/26/2007 5:42:39 PM](https://reader033.vdocuments.us/reader033/viewer/2022050101/5f407c5e8bb2152da37b6254/html5/thumbnails/7.jpg)
Mortality for COPD in Slovakia
0
2
4
6
8
10
12
14
16
18
1997 1998 1999 2000 2001 2002 2003
![Page 8: GARD –Slovakexperience · Microsoft PowerPoint - 1_Zakopane.ppt Author: deslooverep Created Date: 3/26/2007 5:42:39 PM](https://reader033.vdocuments.us/reader033/viewer/2022050101/5f407c5e8bb2152da37b6254/html5/thumbnails/8.jpg)
Structure of cases of invalidity in 2005
Respiratory
49,23%
Gastrointestinal
5,91%
Injuries
6,47%
Other diseases
18,78%
Musculoskeletal
6,47%
GOVERMENTAL DOCUMENT OF SRGOVERMENTAL DOCUMENT OF SR
![Page 9: GARD –Slovakexperience · Microsoft PowerPoint - 1_Zakopane.ppt Author: deslooverep Created Date: 3/26/2007 5:42:39 PM](https://reader033.vdocuments.us/reader033/viewer/2022050101/5f407c5e8bb2152da37b6254/html5/thumbnails/9.jpg)
Overall mortality for respiratory
diseases in Slovakia
• 60-70/100 000
(exceeding the average of European Union)
![Page 10: GARD –Slovakexperience · Microsoft PowerPoint - 1_Zakopane.ppt Author: deslooverep Created Date: 3/26/2007 5:42:39 PM](https://reader033.vdocuments.us/reader033/viewer/2022050101/5f407c5e8bb2152da37b6254/html5/thumbnails/10.jpg)
1645
621
342
0
200
400
600
800
1000
1200
1400
1600
1800
Examined Confirmed
COPD
Newly
diagnosed
COPD
Prevalence of COPD in risk exposure
(37,8%)(37,8%)
(20,8%)(20,8%)
![Page 11: GARD –Slovakexperience · Microsoft PowerPoint - 1_Zakopane.ppt Author: deslooverep Created Date: 3/26/2007 5:42:39 PM](https://reader033.vdocuments.us/reader033/viewer/2022050101/5f407c5e8bb2152da37b6254/html5/thumbnails/11.jpg)
Lung cancer
• Mortality: about 2000 persons a year
• 85% diagnosed in late, inoperable
stage
• Incidence in Slovakia: 70/100 th. M
12/100 th. F
![Page 12: GARD –Slovakexperience · Microsoft PowerPoint - 1_Zakopane.ppt Author: deslooverep Created Date: 3/26/2007 5:42:39 PM](https://reader033.vdocuments.us/reader033/viewer/2022050101/5f407c5e8bb2152da37b6254/html5/thumbnails/12.jpg)
![Page 13: GARD –Slovakexperience · Microsoft PowerPoint - 1_Zakopane.ppt Author: deslooverep Created Date: 3/26/2007 5:42:39 PM](https://reader033.vdocuments.us/reader033/viewer/2022050101/5f407c5e8bb2152da37b6254/html5/thumbnails/13.jpg)
Incidence of TB 2006 - Europe
World Health Organization
Regional Office for Europe
< 10
10-24
25-49
50-99
> 100
Range of rates (per 100 000)
![Page 14: GARD –Slovakexperience · Microsoft PowerPoint - 1_Zakopane.ppt Author: deslooverep Created Date: 3/26/2007 5:42:39 PM](https://reader033.vdocuments.us/reader033/viewer/2022050101/5f407c5e8bb2152da37b6254/html5/thumbnails/14.jpg)
0,0
20,0
40,0
60,0
80,0
100,0
120,0
140,0
160,0
180,0
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44
TB Slovakia 1960-2005
Incidence in 2005 – 732 cases (13,6/100 000)
![Page 15: GARD –Slovakexperience · Microsoft PowerPoint - 1_Zakopane.ppt Author: deslooverep Created Date: 3/26/2007 5:42:39 PM](https://reader033.vdocuments.us/reader033/viewer/2022050101/5f407c5e8bb2152da37b6254/html5/thumbnails/15.jpg)
Task forces for Slovak GARD
(SARD)
• Identification (quite satisfactorily)
• Measures:
Antismoking campaign (40% people from the
age of 17 smoke; 2/3 regularly)
LTOT (1200 oxygenators needed, 800 in use)
Home care for chronically diseased
Funds
![Page 16: GARD –Slovakexperience · Microsoft PowerPoint - 1_Zakopane.ppt Author: deslooverep Created Date: 3/26/2007 5:42:39 PM](https://reader033.vdocuments.us/reader033/viewer/2022050101/5f407c5e8bb2152da37b6254/html5/thumbnails/16.jpg)
ThankThankThank youyouyou forforfor youryouryour attentionattentionattention